Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANS-6637 for Opioid Use Disorder (SEARCH)
NCT04169360Phase 2Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 2021
- Primary completion
- Jan 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of ANS-6637 in opioid use disorder (OUD), sponsored by University of Maryland, Baltimore. Primary endpoint: Number of Grade 3-4 events, Grade 2 Significant event at 16 weeks. Planned start Jan 2021; status: withdrawn.
02
Drugs
ANS-6637
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04169360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04169360.